Pancreatic Cancer Screening Test Study in Japan
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a new blood test called the Enzeavour Assay to screen for early signs of pancreatic cancer in people without symptoms. If the test is positive, you may need imaging tests like an ultrasound or CT scan to confirm findings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with no current pancreatic cancer symptoms attending a health checkup or cancer screening in Japan
- You are willing and able to provide written consent to participate
- You have never been diagnosed with pancreatic cancer
- If your screening test is positive, you must be able and willing to undergo follow-up imaging tests (ultrasound, specialized CT, or endoscopic ultrasound)
- You are in overall good enough health to safely participate, as determined by the study doctor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at blood or tissue samples from people with pancreatic cancer and from those without it. The goal is to find ways to detect the cancer earlier.
This study is testing if measuring a substance called elastase-1, along with standard tests, can help find pancreatic cancer earlier. It may benefit people who already have signs of pancreatic disease or are at high risk.
This study uses stored blood samples from people at higher risk for pancreatic cancer (due to family history or certain pancreatic cysts) to see if a simple blood test can detect the disease early or help monitor it over time.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This trial uses a blood test (called cfDNA) to look for early signs of pancreatic cancer. It compares results from people with pancreatic cancer, precancerous changes, non-cancerous pancreatic conditions, and healthy individuals to improve early detection.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.